Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Denali Therapeutics (DNLI) Change in Account Payables (2017 - 2026)

Denali Therapeutics has reported Change in Account Payables over the past 9 years, most recently at -$3.4 million for Q4 2025.

  • Quarterly Change in Account Payables fell 365.01% to -$3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.5 million through Dec 2025, down 623.31% year-over-year, with the annual reading at -$7.5 million for FY2025, 623.31% down from the prior year.
  • Change in Account Payables was -$3.4 million for Q4 2025 at Denali Therapeutics, up from -$4.1 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $4.8 million in Q2 2023 and troughed at -$4.4 million in Q3 2024.
  • The 5-year median for Change in Account Payables is $708500.0 (2021), against an average of $116350.0.
  • Year-over-year, Change in Account Payables soared 626.11% in 2021 and then crashed 2098.72% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at -$78000.0 in 2021, then crashed by 2098.72% to -$1.7 million in 2022, then dropped by 21.34% to -$2.1 million in 2023, then soared by 161.8% to $1.3 million in 2024, then plummeted by 365.01% to -$3.4 million in 2025.
  • Per Business Quant, the three most recent readings for DNLI's Change in Account Payables are -$3.4 million (Q4 2025), -$4.1 million (Q3 2025), and $2.6 million (Q2 2025).